Wellgistics Health, INC Form 4 insider transactions

Director Surendra K. Ajjarapu acquired 100,000 shares of Wellgistics Health, Inc. common stock through the conversion of warrants.

Prashant Patel, CEO of Wellgistics Health, Inc., acquired 100,000 shares of common stock through the conversion of warrants.

Wellgistics Health, Inc. reports that CEO Prashant Patel was issued 5,000,000 shares of common stock and 5,000,000 warrants as compensation for services.

Wellgistics Health, Inc. reports that Director Surendra K. Ajjarapu was issued 5,000,000 shares of common stock and 5,000,000 warrants as compensation for services.

CEO Prashant Patel acquired 5,000,000 shares and 5,000,000 warrants of Wellgistics Health, Inc. as compensation for services.

Director Surendra K. Ajjarapu acquired 5,000,000 shares and 5,000,000 warrants of Wellgistics Health, Inc. as compensation for services.

Wellgistics Health, Inc. Director Michael Peterson has acquired 200,000 shares of common stock at $0.9 per share through a pre-planned Rule 10b5-1(c) transaction, with shares vesting over three years.

Shafaat Pirani, Chief Clinical Officer of Wellgistics Health, Inc., reports acquiring 35,000 shares of restricted stock under the company's equity incentive plan.

Director Sajid Syed reports acquisition of 200,000 shares of Wellgistics Health common stock, along with details of vesting schedule for restricted stock.

Director Surendra Ajjarapu reports acquisition and disposal of Wellgistics Health stock, including restricted shares, impacting his direct and indirect holdings.

Prashant Patel, Chief Strategy Officer of Wellgistics Health, reports acquiring and disposing of common stock, as well as holding shares indirectly through multiple entities and a trust.

Donald Anderson, a director at Wellgistics Health, acquired 200,000 shares of common stock on March 21, 2025, and disposed of shares resulting in a total of 244,720 shares beneficially owned.

Wellgistics Health CEO Brian Norton acquired 9,000,000 shares of restricted stock on March 21, 2025, contingent upon achieving specific financial metrics.

Nikul Panchal, Chief Pharmacy Officer of Wellgistics Health, reports acquisition of common stock and restricted stock units.

Rebecca Shanahan, a director at Wellgistics Health, acquired 200,000 shares of common stock and disposed of an unspecified amount, according to a recent SEC filing.